H.R. 6083 (111th): Stem Cell Therapeutic and Research Reauthorization Act of 2010

The federal budget process occurs in two stages: appropriations, which set overall spending limits by agency or program, and authorizations, which direct how federal funds should (or should not) be used. Appropriation and authorization provisions are typically made for single fiscal years. A reauthorization bill like this one renews the authorizations of an expiring law.

Aug 10, 2010
111th Congress, 2009–2010

Enacted as S. 3751 (companion bill)

Christopher “Chris” Smith

Representative for New Jersey's 4th congressional district



Read Text »
Last Updated: Aug 10, 2010
Length: 10 pages

See Instead:

S. 3751 (same title)
Enacted — Signed by the President — Oct 8, 2010

H.R. 6081 (same title)
Reported by Committee — Sep 23, 2010

About the bill

Full Title

To amend the Stem Cell Therapeutic and Research Act of 2005.

The bill’s title was written by its sponsor.

Read CRS Summary >


Aug 10, 2010

This is the first step in the legislative process.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.


4 cosponsors (3D, 1R) (show)
Committee Assignments

The committee chair determines whether a bill will move past the committee stage.


There have been no roll call votes related to this bill.

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

H.R. 2820 (114th) was a re-introduction of this bill in a later Congress.

Enacted — Signed by the President
Dec 18, 2015

S. 3751 (identical)

Enacted — Signed by the President
Oct 8, 2010

Search for similar bills.

Links & tools

Primary Source


Congress.gov is updated generally one day after events occur. Legislative activity since the last update may not be reflected on GovTrack. Data via congress project.


Click a format for a citation suggestion: